s

Alienum phaedrum torquatos nec eu, vis detraxitssa periculiser ex, nihil expetendis in mei eis an pericula es aperiri deprecatis.

Author: admin

Advances in imaging technology for early detection of mesothelioma as well as immunotherapy used in multimodal treatments have recently shown great promise to extend life expectancy for mesothelioma patients. Now, another adjuvant treatment is being developed for treating pleural mesothelioma called non-ablative hypofractionated hemithoracic radiation treatment....

Journal of Thoracic Oncology 2018 October 23 [Link] Harris EJ, Kao S, McCaughan B, Nakano T, Kondo N, Hyland R, Nowak AK, de Klerk NH, Brims FJ Abstract BACKGROUND: Malignant Pleural Mesothelioma (MPM) is an uncommon cancer with a poor prognosis and heterogeneous survival. Surgery for MPM is offered...